Arrayit Corporation (OTCBB:ARYC), a leader in life sciences and healthcare technology, announces today that the company has added 128 new products to its widely-used portfolio of life sciences tools. Arrayit now offers 836 life sciences products to researchers worldwide, all of which can be purchased on-line 24 hours a day at the Arrayit Store. The company has recorded $36.2M in product revenue in the Arrayit Store since its inception.
Arrayit microarrays, which are miniature glass substrates containing microscopic spots of genes and proteins, offer up to 10 times the sensitivity of competing platforms and allow researchers to diagnose as many as 100,000 patients on a single chip. These attributes provide a significant competitive advantage when studying complex biological pathways such as human disease. Arrayit provides a comprehensive microarray technology platform including VIP™ genotyping packages, biomarker discovery services, whole human genome chips, protein microarrays, microarray printing robots, microarray pins and printheads, fluorescence and colorimetric scanners, personal instruments, software products, glass substrate slides, purification kits, buffers and solutions, and many other products used by scientists and doctors on a daily basis.
Arrayit CEO and Chairman Rene Schena states, "The versatility and effectiveness of the Arrayit platform provides an ongoing opportunity for licensing and new product revenues for Arrayit Corporation, as we continue to support the expanding needs of the scientific community."
UK's drug payment disclosure system fails to protect patients and public trust